Immuno Series UK24 - 25 August 2020 | London, UK

Join over 350 leaders at the forefront of research into the immune system, connecting experts from pharma, biotech and academia working on the delivery of innovative immunotherapies

The Immuno Series features 2 outstanding programmes consisting of key discussion topics in Immuno-Oncology, Autoimmunity, Immunology and Inflammation, enabling attendees to gain actionable insights into the approaches impacting this field from the leading immunotherapy experts.

Key Speakers

The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

partha chowdhury

Partha Chowdhury

Sanofi

Céline Adessi

Celine Adessi

F. Hoffmann-La Roche Ltd.

Mahendra Deonarain, Antikor Biopharma

Mahendra Deoharian

Antikor BioPharma

Andrew_Exley

Andrew Exley

MHRA

Mario Ehlers

Mario Ehlers

Boehringer Ingelheim

Sonya Abraham

Sonya Abraham

UCB

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of on-site experiences.

Networking Drinks & Dinner

Relax after a busy first day at the event with access to the vibrant drink’s reception followed by dinner

Women in Immunology Symposium

A platform for female speakers to share their research and experience, highlighting the ground-breaking work being completed by women in immunology

Panel Discussion

A deep dive into the best strategies to translate a proof of concept into the clinic

Roundtable Discussions

Discussions on key industry growth areas within immuno-oncology and autoimmunity

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.

Calling all Immunologists!

With a key priority in the IO industry centring around developing effective combination therapies, we are currently preparing a detailed market survey to provide the community with insights from leading experts into their strategies for this, the technologies they require and any bottlenecks.

Have your say in our Immuno-Oncology Market Survey & win an iPad Mini 4!